Correlation Between Cytek Biosciences and Agilon Health

Can any of the company-specific risk be diversified away by investing in both Cytek Biosciences and Agilon Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytek Biosciences and Agilon Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytek Biosciences and agilon health, you can compare the effects of market volatilities on Cytek Biosciences and Agilon Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytek Biosciences with a short position of Agilon Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytek Biosciences and Agilon Health.

Diversification Opportunities for Cytek Biosciences and Agilon Health

0.03

Correlation Coefficient

Cytek Biosciences  Agilon Health

Significant diversification

The 3 months correlation between Cytek and Agilon is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and agilon health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on agilon health and Cytek Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytek Biosciences are associated (or correlated) with Agilon Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of agilon health has no effect on the direction of Cytek Biosciences i.e., Cytek Biosciences and Agilon Health go up and down completely randomly.

Pair Corralation between Cytek Biosciences and Agilon Health

Given the investment horizon of 90 days Cytek Biosciences is expected to generate 0.72 times more return on investment than Agilon Health. However, Cytek Biosciences is 1.39 times less risky than Agilon Health. It trades about 0.03 of its potential returns per unit of risk. agilon health is currently generating about -0.22 per unit of risk. If you would invest  379.00  in Cytek Biosciences on May 8, 2025 and sell it today you would earn a total of  9.50  from holding Cytek Biosciences or generate 2.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cytek Biosciences  vs.  agilon health

Cytek Biosciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward-looking signals, Cytek Biosciences may actually be approaching a critical reversion point that can send shares even higher in September 2025.

agilon health

Risk-Adjusted Performance

Weakest

Over the last 90 days agilon health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in September 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Cytek Biosciences and Agilon Health

The main advantage of trading using opposite Cytek Biosciences and Agilon Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytek Biosciences position performs unexpectedly, Agilon Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilon Health will offset losses from the drop in Agilon Health's long position.

The idea behind Cytek Biosciences and agilon health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.